Dental/medical anxiety/phobia remediation protocol
A protocol or procedure is provided for lowering sympathetic nervous system arousal in a person in order to prepare that person for a medical or dental procedure. First, a therapeutic dosage of one or more neurotransmitter supplements, such as a gamma aminobutyric acid formulation, a tryptophan-derived neurotransmitter, and dehydroepiandrosterone are sublingually administered to the patient. After a period of time for the formula dosage to take effect, gelled electrodes are placed adjacent or below the mastoid. The gelled electrodes are connected to a cranial electrotherapy stimulation device that administers a sub-sensation level current to the patient. Also, a noise dampening headset is placed on the patient and a neuroacoustic entrainment recording or program is played. Then, the medical or dental procedure is performed.
1 . A method of relaxing a patient before and during a dental procedure comprising the steps of:
administering a therapeutic dosage of a neurotransmitter supplement to the patient;
administering cranial electrotherapy stimulation to the patient;
administering a neuroacoustic entrainment program to the patient to promote lower-frequency brainwave patterns, the neuroacoustic entrainment program comprising signals of two different frequencies presented separately and simultaneously to each ear, the program inducing the brain to perceive a phantom frequency equal to the difference between the two frequencies presented to the ears; and
performing the dental procedure on the patient.
2 . The method of claim 1 , wherein the step of administering a therapeutic dosage of a neurotransmitter supplement precedes the administration of cranial electrotherapy stimulation and a neuroacoustic entrainment program.
3 . The method of claim 2 , wherein the administration of cranial electrotherapy stimulation and a neuroacoustic entrainment program are done concomitantly.
4 . The method of claim 1 , further comprising the step of seating the person in a piece of furniture that supports a person in a reclining position.
5 . The method of claim 4 , wherein the person is first seated, then administered a therapeutic dosage of a neurotransmitter supplement, and thereafter administered cranial electrotherapy stimulation and a neuroacoustic entrainment program.
6 . The method of claim 1 , wherein the step of administering a therapeutic dosage of a neurotransmitter supplement precedes the steps of administering cranial electrotherapy stimulation and administering a neuroacoustic entrainment program.
7 . The method of claim 1 , wherein the neurotransmitter supplement is administered sublingually.
8 . The method of claim 1 , wherein the neurotransmitter supplement comprises a gamma aminobutyric acid formulation.
9 . The method of claim 1 , wherein the neurotransmitter supplement comprises tryptophan or a tryptophan derivative.
10 . The method of claim 1 , further comprising administering dehydroepiandrosterone to the patient.
11 . The method of claim 1 , wherein the step of administering cranial electrotherapy stimulation comprises delivering current transcranially via gelled electrodes placed adjacent or below the mastoid.
12 . The method of claim 1 , wherein the step of administering cranial electrotherapy stimulation comprises delivering current at a sub-sensation intensity level.
13 . The method of claim 1 , wherein the neuroacoustic entrainment program is administered to the patient through a noise dampening headset.
14 . The method of claim 1 , wherein the neuroacoustic entrainment program comprises multiple layered binaural signals that promote multiple lower-frequency brainwave patterns.
15 . The method of claim 1 , wherein the neuroacoustic entrainment program blends instrumental music or sounds of nature with the binaural signals.
16 . The method of claim 1 , further comprising administering additional dosages of neurotransmitter supplements to the patient during the dental procedure.
17 . A method of lowering sympathetic nervous system arousal in a person in order to prepare that person for a medical or dental procedure, the method comprising the steps of:
administering a therapeutic dosage of a neurotransmitter supplement to the person;
administering cranial electrotherapy stimulation to the person; and
administering a neuroacoustic entrainment program to the person to promote lower-frequency brainwave patterns, the neuroacoustic entrainment program comprising binaural signals of two different frequencies presented separately and simultaneously to each ear, the program inducing the brain to perceive a phantom frequency equal to the difference between the two frequencies presented to the ears.